# Fructose in Exercising Individuals With Type 1 Diabetes Using Insulin Degludec

> **NCT03497260** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 15 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus
- Diabetes Complications

## Interventions

- **DIETARY_SUPPLEMENT:** Fructose
- **OTHER:** Plain water

## Key facts

- **NCT ID:** NCT03497260
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-04
- **Primary completion:** 2019-09-06
- **Final completion:** 2019-09-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03497260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03497260, "Fructose in Exercising Individuals With Type 1 Diabetes Using Insulin Degludec". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03497260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*